Prevalence of HBV Sero-markers in two Di f ferent Socioeconomic Groups of Schoolchildren from Abidjan, Côte d’ Ivoire

Marie-Jeanne Lohouès-Kouacou, Constant Assi, Aline Simen-Kapeu, AD Badje, Siaka Koné, Amadou Ouattara, Dramane Soro, Benoit-Mathieu Camara

Abstract


AIM: To assess seroprevalence of hepatitis B markers according to the social condition, in schoolchildren born before newborns immunization in Abidjan. METHODS: A total of 253 schoolchildren (6 to 15 years) were recruited in two randomly selected primary schools between April and June 2006. Schools A (n=124) and B (n=129) respectively were attended by schoolchildren from poorest and high social conditions. Serum samples were analyzed for serological markers of hepatitis B (ELISA method) to determine if they were infected, healed, vaccinated or seronegative. Logistic regression was performed to research the relationship between being infected or vaccinated and social condition, age and sex. RESULTS: Overall, children infected, healed and vaccinated were 4.3% (n=11), 6.3% (n=16) and 45.9% (n=116). No Hepatitis B Virus seromarkers were found in 121 cases (47.8%). In univariate analysis infected status increasing (0.8% vs 8.1% P=0.004) and vaccinated status decreasing (80.8% vs 8.9% P<0.00001) in poor social condition. In logistic regression, infected status was associated with increasing age [Odds Ratio (OR): 4.3; P=0.001; 95% confidence interval: 1.7-10.5] and poorest social condition [Odds Ratio (OR); 12.6; P=0.00; 95% confidence interval (CI): 2.9-55.7]; and vaccinated status was only associated with high social condition [Odds Ratio 64 (25.2-162.5) P<0.001]. No relation was found between sex and vaccinated [Odds Ratio (OR): 1.9; P=0.083; 95% confidence interval (CI): 0.9-4.1] or infected [Odds Ratio (OR): 1.9; P=0.168; 95% confidence interval (CI): 0.8-4.5)] status. CONCLUSION: In Abidjan, poorest social class is associated with low immunization coverage and high infected status in schoolchildren born before hepatitis B universal vaccination. Catchup immunization in necessary and must be free of charge to be effective.

Keywords


Hepatitis B seroprevalence; Vaccination; Schoolchildren; Socioeconomic level; Catch up immunization

References


World Health Organization – Hepatitis B vaccines. Weekly

Epidemiological Record 2009; 40: 405-420

Lavanchy D. Hepatitis B virus epidemiology, disease

burden, treatment, and current and emerging prevention

and control measure. J Viral Hepat 2004; 11: 97-107

Lohouès-Kouacou MJ, Touré M, Hillah J, Camara BM, N'Dri

N, Kouamé KJ, Attia Y. Materno-foetal transmission of

hepatitis B virus in Ivory Coast. Plea for mass vaccination.

Sante 1998; 8: 401-104

Bile K, Mohamud O, Aden C, Isse A, Norder H, Nilsson

L, Magnius L. The risk for hepatitis A, B, and C at

two institutions for children in Somalia with different

socioeconomic conditions. Am J Trop Med Hyg 1992; 47:

-364

Jafri W, Jafri N, Yakoob J, Islam M, Tirmizi SFA, Jafar T,

Akhtar S, Hamid S, Shah HA, Nizami SQ. Hepatitis B and

C: prevalence and risk factors associated with seropositivity

among children in Karachi, Pakistan. BMC Infectious Diseases

, 6: 101-111

Gandolfo GM, Ferri GM, Conti L, Antenucci A, Marrone R,

Frasca AM, Vitelli G. Prevalence of infections by hepatitis A,

B, C and E viruses in two different socioeconomic groups of

children from Santa Cruz, Bolivia. Med Clin (Barc) 2003; 24;

: 725-727

Chiaramonte M, Stroffolini T, Ngatchu T, Rapicetta M,

Lantum D, Kaptue L, Chionne P, Conti S, Sarrecchia B,

Naccarato R. Hepatitis B virus infection in Cameroon: a

seroepidemiological survey in city school children. J Med

Virol 1991; 33: 95-99

D a v a a l k h a m D , O j i m a T , N y m a d a w a P , T s e n d N ,

Lkhagvasuren T, Wiersma S, Uehara R, Watanabe M,

Oki I, Nakamura Y. Seroepidemiology of hepatitis B

virus infection among children in Mongolia: results of a

nationwide survey. Pediatr Int 2007; 49: 368-374

M a g o n i M , E k r a K D , A k a L N , S i t a K S , K a n g a K .

Effectiveness of hepatitis-B vaccination in Ivory Coast: the

case of the Grand Bassam health district. Ann Trop Med

Parasito 2009; 103: 519-527

Migliani R, Rousset D, Rakoto-Andrianarivelo M,

Rabarijaona L, Ratsitorahina M, Rajaonarivony V, Mauclère

P. Hepatitis B virus infection: a public health problem in

Madagascar. Arch Inst Pasteur Madagascar 2000; 66: 50-54

Rui WZ, Lo Baïdy B, N'Diaye M.. Hepatitis B virus infection

in the school milieu of Kiffa and Selibaby, Mauritania. Bull

Soc Pathol Exot 1998; 91: 247-248

Alikor EA, Erhabor ON. Seroprevalence of hepatitis

B surface antigenaemia in children in a tertiary health

institution in the Niger Delta of Nigeria. Niger J Med 2007;

: 250-251

Martinson FE, Weigle KA, Mushahwar IK, Weber DJ, Royce

R, Lemon SM. Seroepidemiological survey of hepatitis B

and C virus infections in Ghanaian children. J Med Virol

; 48: 278-283

Abebe A, Nokes DJ, Dejene A, Enquselassie F, Messele T,

Cutts FT. Seroepidemiology of hepatitis B virus in Addis

Ababa, Ethiopia: transmission patterns and vaccine control.

Epidemiol Infect 2003; 131: 757-770

Assi C, Ouattara A, Allah Kouadio E, Diakite M, Koné S,

Lohoues Kouacou MJ, Camara BM. Vaccination coverage

against hepatitis B and prevalence of HBsAg: a crosssectional

study involving 592 persons attending public

screening in Abidjan. Clin Res Hepatol Gastroenterol 2011; 35:

-507

Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe

P, Leroy V, Dabis F, Rouzioux C; ANRS 1236 DITRAMEB&

C Study Group. HBV and HCV prevalence and viraemia

in HIV-positive and HIV-negative pregnant women in

Abidjan, Côte d'Ivoire: the ANRS 1236 study. J Med Virol

; 74: 34-40

Reda AA, Arafa MA, Youssry AA, Wandan EH, Ab de Ati

M, Daebees H. Epidemiologic evaluation of the immunity

against hepatitis B in Alexandria, Egypt. Eur J Epidemiol

; 18: 1007-1011

Ang LW, Tey SH, Cutter J, James L, Goh KT. Seroprevalence

of hepatitis B virus infection among children and

adolescents in Singapore, 2008-2010. J Med Virol 2013; 85:

-588

Vandermeulen C, Roelants M, Theeten H, Depoorter AM,

Van Damme P, Hoppenbrouwers K. Vaccination coverage

in 14-year-old adolescents: documentation, timeliness,

and sociodemographic determinants. Pediatrics 2008; 121:

e428-34.

Michos A, Terzidis A, Kalampoki V, Pantelakis K, Spanos

T, Petridou ET. Seroprevalence and risk factors for hepatitis

A, B, and C among Roma and non-Roma children in a

deprived area of Athens, Greece. J Med Virol 2008; 80:

-797

Dowd JB, Zajacova A, Aiello A. Early origins of health

disparities: burden of infection, health, and socioeconomic

status in U.S. children. Soc Sci Med 2009; 68: 699–707

Ategbo S, Ngoungou EB, Koko J, Vierin Y, Zang Ndong

CE, Moussavou Mouyama A. Immunization coverage of

children aged 0 to 5 years in Libreville (Gabon). Sante 2010;

: 215-219

Chang MH, Chen TH, Hsu HM, Wu TC, Kong MS, Liang

DC, Ni YH, Chen CJ, Chen DS; Taiwan Childhood HCC

Study Group. Prevention of hepatocellular carcinoma by

universal vaccination against hepatitis B virus: the effect

and problems. Clin Cancer Res 2005; 11: 7953-7957

Ni YH, Chen DS. Hepatitis B vaccination in children: the

Taiwan experience. Pathol Biol (Paris) 2010; 58: 296-300


Full Text: PDF HTML

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.